Diabetes and dyslipidemia

KR Feingold, C Grunfeld - Diabetes and Cardiovascular Disease, 2023 - Springer
type 1 and type 2 diabetes. There are numerous risk factors that contribute to the increased
risk of ASCVD, but dyslipidemia … of gouty attacks are major side effects of bempedoic acid [45]…

Mechanisms and treatment of dyslipidemia in diabetes

E Bahiru, R Hsiao, D Phillipson, KE Watson - Current cardiology reports, 2021 - Springer
Type 2 diabetes mellitus is widespread throughout the world and is a powerful risk factor for
the … This manuscript explored the mechanisms underlying dyslipidemia in type 2 diabetes as …

Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at Jimma University Medical Center, Jimma, Southwest Ethiopia

K Haile, A Timerga - Diabetes, Metabolic Syndrome and Obesity, 2020 - Taylor & Francis
… on the prevalence of dyslipidemia and associated factors in diabetic patients in Ethiopia as
type 1 and type 2 diabetes. Citation19 Timely detection and characterization of dyslipidemia

Dyslipidemia management in adults with diabetes

J Lazarte, RA Hegele - Canadian journal of diabetes, 2020 - Elsevier
… susceptibility in type 2 diabetes results from multifaceted dyslipidemia characterized … side
effects, this agent is unlikely to be used in Canada for management of dyslipidemia in diabetes

[HTML][HTML] Management of diabetic dyslipidemia: An update

I Jialal, G Singh - World journal of diabetes, 2019 - ncbi.nlm.nih.gov
Diabetic dyslipidemia is a cluster of lipoprotein abnormalities … It is extremely common in type
2 diabetes (T2DM) affecting … in diabetic patients > 75 years taking into account side effects

Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta‐analysis of randomized …

D Li, T Wu, T Wang, H Wei, A Wang… - … and Drug Safety, 2020 - Wiley Online Library
… oral glucose-lowering drugs in patients with type 2 diabetes mellitus and reported the events
of … type 2 diabetes showed no significant effects of SGLT2 inhibitors on risk of dyslipidemia. …

Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study

AD Kaze, P Santhanam, SK Musani… - Journal of the …, 2021 - Am Heart Assoc
dyslipidemia in cardiovascular disease risk stratification among people with type 2 diabetes
… elevated prevalence of risk factors including obesity and type 2 diabetes mellitus (T2DM). , …

An update on pharmacotherapies in diabetic dyslipidemia

M Gupta, R Tummala, RK Ghosh, C Blumenthal… - Progress in …, 2019 - Elsevier
… In all patients with type 2 diabetes and no additional risk factors and/or evidence of target …
had similar rates of overall adverse effects and serious adverse effects, but was associated …

[HTML][HTML] Long-term complications in youth-onset type 2 diabetes

TODAY Study Group - New England Journal of Medicine, 2021 - Mass Medical Soc
… The cumulative incidence of hypertension was 67.5%, the incidence of dyslipidemia was
51.6%, the incidence of diabetic kidney disease was 54.8%, and the incidence of nerve …

[HTML][HTML] Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus

JP Kane, CR Pullinger, ID Goldfine… - Current opinion in …, 2021 - Elsevier
… C-III in both type 1 diabetes [23] and in type 2 diabetes [24]. … to the risk of type 2 diabetes,
hepatic gluconeogenesis, and … that the adverse effects of statins may be owing to effects on …